Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Boehringer Ingelheim
Merck
Mallinckrodt
Harvard Business School

Last Updated: January 29, 2020

DrugPatentWatch Database Preview

TESTOSTERONE ENANTHATE Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Testosterone Enanthate patents expire, and when can generic versions of Testosterone Enanthate launch?

Testosterone Enanthate is a drug marketed by Hikma Farmaceutica, Mylan Institutional, Nexus Pharms, Watson Labs, and Watson Pharms Inc. and is included in eight NDAs.

The generic ingredient in TESTOSTERONE ENANTHATE is estradiol valerate; testosterone enanthate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol valerate; testosterone enanthate profile page.

Drug patent expirations by year for TESTOSTERONE ENANTHATE
Drug Prices for TESTOSTERONE ENANTHATE

See drug prices for TESTOSTERONE ENANTHATE

Recent Clinical Trials for TESTOSTERONE ENANTHATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The University of Texas Medical Branch, GalvestonPhase 2/Phase 3
Shalendar Bhasin, MDPhase 2
National Institute on Aging (NIA)Phase 2

See all TESTOSTERONE ENANTHATE clinical trials

Recent Litigation for TESTOSTERONE ENANTHATE

Identify potential future generic entrants

District Court Litigation
Case NameDate
Antares Pharma Inc. v. Medac Pharma Inc.2014-07-21

See all TESTOSTERONE ENANTHATE litigation

Pharmacology for TESTOSTERONE ENANTHATE
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Synonyms for TESTOSTERONE ENANTHATE
(8R,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl heptanoate
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate
11111-10-7
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17-[(1-Oxoheptyl)oxy]androst-4-en-3-one
17-heptanoyl-17beta-hydroxyandrost-4-en-3-one
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
17beta-hydroxyandrost-4-en-3-one heptanoate
3-Oxoandrost-4-en-17-yl heptanoate, (17.beta.)- #
3-oxoandrost-4-en-17beta-yl heptanoate
315-37-7
315T377
4-08-00-00979 (Beilstein Handbook Reference)
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17.beta.-enanthate
4-Androsten-3-one 17beta-enanthate
7Z6522T8N9
91337-EP2284149A1
91337-EP2305636A1
AC-12599
AC1L1SZP
AKOS015960945
AN-44241
Andro L.A. 200
Androgyn L.A
Androgyn L.A.
Androgyn L.A. (Salt/Mix)
Andropository
Androst-4-en-3-one, 17-((1-oxoheptyl)oxy)-, (17beta)-
Androst-4-en-3-one, 17-(1-oxoheptyl)oxy-, (17beta)-
Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17.beta.)-
Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17b)-
Androst-4-en-3-one, 17.beta.-hydroxy-, heptanoate
Androst-4-en-3-one, 17beta-hydroxy-, heptanoate
Androst-4-en-3-one, heptanoate
Androst-4-en-3-one,(17.beta.)-
Androtardyl
Atlatest
BRN 3170544
C-21720
C08157
C26H40O3
CC-34818
CCRIS 7082
CHEBI:9464
CHEMBL1200335
D00958
DEA No. 4000
Deladumone (Salt/Mix)
Delatest
Delatestryl (TN)
DePatestrye
Depo-Testro Med
Ditate
Ditate (Salt/Mix)
DS-11585
Durathate
EINECS 206-253-5
Enanthic acid testosterone
Everone
Exten test
Heptanoic acid, ester with testosterone
LMST02020075
LS-148818
Malogen L.A
Malogen L.A.
Malogen L.A.200
MolPort-003-959-707
NSC-17591
NSC17591
Orquisteron-E
Primotestone
Reposo TMD
Reposo-TMD
SC-16227
SCHEMBL42687
SR-01000942262
SR-01000942262-1
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosterone 17-enanthate
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone enantate
Testosterone enantate for peak identification, European Pharmacopoeia (EP) Reference Standard
Testosterone enantate for system suitability, European Pharmacopoeia (EP) Reference Standard
Testosterone enantate, European Pharmacopoeia (EP) Reference Standard
Testosterone enanthate (JP17/USP)
Testosterone enanthate [USAN:JAN]
Testosterone enanthate [USP:JAN]
Testosterone enanthate, analytical standard
Testosterone enanthate, United States Pharmacopeia (USP) Reference Standard
Testosterone ethanate
Testosterone heptanoate
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testosterone, heptanoate
Testostroval
Theramex
UNII-7Z6522T8N9
VOCBWIIFXDYGNZ-IXKNJLPQSA-N
W-106891
WLN: L E5 B666 OV MUTJ A E FOV6
ZINC3876080

US Patents and Regulatory Information for TESTOSTERONE ENANTHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 091120-001 Sep 18, 2012 AO RX No No   Start Trial   Start Trial   Start Trial
Watson Pharms Inc TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 085598-001 Approved Prior to Jan 1, 1982 AO RX No Yes   Start Trial   Start Trial   Start Trial
Watson Labs TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 083667-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE estradiol valerate; testosterone enanthate INJECTABLE;INJECTION 085865-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Institutional TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 040647-001 Oct 5, 2009 DISCN No No   Start Trial   Start Trial   Start Trial
Nexus Pharms TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 040575-001 Jun 14, 2006 AO RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Harvard Business School
Merck
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.